Immunotherapy harnesses and enhances the body’s own immune system to better recognize and eliminate cancer.

 

​At Cellmover, we are advancing this frontier with three promising drug candidates targeting intracellular proteins in immune cells. Since approximately 61% of the human proteome resides inside cells, intracellular biologics open a new frontier in precision medicine — enabling the targeting of previously “undruggable” proteins and transforming how cancer and other diseases are treated.